| Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia (NCT00119340) | Fred Hutchinson Cancer Center | 2005-04-01 |
| Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (NCT00118196) | Medical University of South Carolina | 2005-04-01 |
| 05-001: Treatment of Acute Lymphoblastic Leukemia in Children (NCT00400946) | Dana-Farber Cancer Institute | 2005-04-01 |
| Metabolic Syndrome in Childhood Cancer Survivors (NCT00920738) | University of Minnesota | 2005-04-01 |
| Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease (NCT00295971) | University of California, San Francisco | 2005-04-01 |
| Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma (NCT00185731) | Dean Felsher | 2005-04-01 |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00109837) | SWOG Cancer Research Network | 2005-04-01 |
| Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT01378416) | Eisai Inc. | 2005-04-01 |
| Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (NCT00920842) | Fred Hutchinson Cancer Center | 2005-04-01 |
| Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT00112554) | Vion Pharmaceuticals | 2005-03-01 |
| Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia (NCT00258271) | University of Rochester | 2005-03-01 |
| Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies (NCT00990717) | University Health Network, Toronto | 2005-03-01 |
| Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 (NCT00898469) | Children's Oncology Group | 2005-03-01 |
| BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate (NCT00112775) | Jonsson Comprehensive Cancer Center | 2005-03-01 |
| Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients (NCT00186940) | St. Jude Children's Research Hospital | 2005-03-01 |
| Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 (NCT00149162) | Assistance Publique - Hôpitaux de Paris | 2005-03-01 |
| Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant (NCT00231712) | Julius-Maximilians University | 2005-03-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT00274846) | Masonic Cancer Center, University of Minnesota | 2005-03-01 |
| Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00104975) | Yale University | 2005-02-01 |
| A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes (NCT00324129) | Mirati Therapeutics Inc. | 2005-02-01 |
| Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia (NCT00105313) | MedImmune LLC | 2005-02-01 |
| A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia (NCT01656031) | Wake Forest University Health Sciences | 2005-02-01 |
| Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer (NCT00104923) | California Cancer Consortium | 2005-02-01 |
| A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes (NCT00324194) | Mirati Therapeutics Inc. | 2005-02-01 |
| Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00295841) | Wake Forest University Health Sciences | 2005-02-01 |
| Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00121303) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2005-01-01 |
| Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia (NCT00107523) | Fred Hutchinson Cancer Center | 2005-01-01 |
| Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) (NCT00109031) | Swedish Orphan Biovitrum | 2005-01-01 |
| Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma (NCT00278161) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-01-01 |
| Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders (NCT00301834) | University of California, San Francisco | 2005-01-01 |
| G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission (NCT00233961) | Herbert Irving Comprehensive Cancer Center | 2005-01-01 |
| Behavioral Intervention For BMT/SCT Survivors (NCT00579917) | Memorial Sloan Kettering Cancer Center | 2005-01-01 |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer (NCT00357500) | Dana-Farber Cancer Institute | 2005-01-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia (NCT00436904) | Mayo Clinic | 2004-12-01 |
| Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma (NCT00884286) | PharmaMar | 2004-12-01 |
| MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia (NCT00101179) | National Cancer Institute (NCI) | 2004-11-03 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes (NCT00096135) | Children's Oncology Group | 2004-11-01 |
| Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL (NCT00452374) | M.D. Anderson Cancer Center | 2004-11-01 |
| Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes (NCT00104806) | Wake Forest University Health Sciences | 2004-11-01 |
| Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT00112983) | Jonsson Comprehensive Cancer Center | 2004-11-01 |
| Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia (NCT00940342) | M.D. Anderson Cancer Center | 2004-10-12 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate (NCT00100997) | Jonsson Comprehensive Cancer Center | 2004-10-01 |
| Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia (NCT00458848) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2004-10-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00134004) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-10-01 |
| Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors (NCT00365768) | Columbia University | 2004-10-01 |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia (NCT00276601) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-10-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial (NCT00897767) | Eastern Cooperative Oncology Group | 2004-09-21 |
| Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias (NCT00098436) | Vion Pharmaceuticals | 2004-09-01 |
| Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia (NCT00509600) | M.D. Anderson Cancer Center | 2004-09-01 |
| Alemtuzumab and Pentostatin In T-cell Neoplasms (NCT00453193) | M.D. Anderson Cancer Center | 2004-09-01 |
| Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00301951) | University of California, San Francisco | 2004-09-01 |
| Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia (NCT00313053) | Clare Twist | 2004-09-01 |
| Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate (NCT00093639) | Novartis Pharmaceuticals | 2004-08-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT00093587) | Jonsson Comprehensive Cancer Center | 2004-08-01 |
| S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00066794) | SWOG Cancer Research Network | 2004-07-01 |
| Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma (NCT00214370) | University of Wisconsin, Madison | 2004-07-01 |
| Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia (NCT00230282) | Steven E. Coutre | 2004-07-01 |
| Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00087425) | National Institute on Aging (NIA) | 2004-07-01 |
| Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) (NCT00493129) | M.D. Anderson Cancer Center | 2004-07-01 |
| S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML (NCT00085709) | SWOG Cancer Research Network | 2004-07-01 |
| Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia (NCT00086099) | MedImmune LLC | 2004-07-01 |
| A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia (NCT01126814) | University Health Network, Toronto | 2004-07-01 |
| Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients (NCT00323557) | M.D. Anderson Cancer Center | 2004-06-01 |
| Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (NCT00134017) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-06-01 |
| Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00093366) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) (NCT00086125) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00091234) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-06-01 |
| Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation (NCT00087009) | Memorial Sloan Kettering Cancer Center | 2004-05-01 |
| G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552) | OHSU Knight Cancer Institute | 2004-05-01 |
| Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia (NCT00085176) | Children's Oncology Group | 2004-05-01 |
| Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia (NCT00089050) | Fred Hutchinson Cancer Center | 2004-05-01 |
| Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients (NCT00504920) | M.D. Anderson Cancer Center | 2004-05-01 |
| Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT00081887) | M.D. Anderson Cancer Center | 2004-05-01 |
| LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT00085150) | National Cancer Institute (NCI) | 2004-04-01 |
| Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer (NCT00498719) | M.D. Anderson Cancer Center | 2004-04-01 |
| Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies (NCT00795132) | University of Utah | 2004-04-01 |
| Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease (NCT00521430) | Asan Medical Center | 2004-04-01 |
| RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma (NCT00081874) | M.D. Anderson Cancer Center | 2004-04-01 |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) (NCT00500240) | M.D. Anderson Cancer Center | 2004-04-01 |
| Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation (NCT00080873) | Children's Oncology Group | 2004-04-01 |
| Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia (NCT00100971) | Boston Medical Center | 2004-04-01 |
| Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia (NCT00083070) | Children's Oncology Group | 2004-03-01 |
| Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00096044) | Roswell Park Cancer Institute | 2004-03-01 |
| Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia (NCT00324779) | University Hospital Erlangen | 2004-03-01 |
| Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00217386) | Fred Hutchinson Cancer Center | 2004-03-01 |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia (NCT00077922) | National Cancer Institute (NCI) | 2004-02-29 |
| T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| A Study of Actonel for the Prevention of Bone Loss (NCT00452439) | M.D. Anderson Cancer Center | 2004-02-01 |
| STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors (NCT00088101) | Synta Pharmaceuticals Corp. | 2004-02-01 |
| Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer (NCT00402935) | Case Comprehensive Cancer Center | 2004-02-01 |
| Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes (NCT00075010) | M.D. Anderson Cancer Center | 2004-01-23 |
| 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome (NCT00077558) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00077493) | MedImmune LLC | 2004-01-01 |
| Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) (NCT00075816) | Medical College of Wisconsin | 2004-01-01 |
| Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 (NCT00896701) | Alliance for Clinical Trials in Oncology | 2004-01-01 |
| T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases (NCT00589602) | The Cleveland Clinic | 2004-01-01 |